BCAT1 and cancer: In human AML stem cells, BCAT1 is overexpressed, and the BCAA pathway is activated by the low levels of α-KG, displaying a DNA hypermethylation phenotype similar to IDH mutant-positive cancers (Raffel et al., 2017).